Related Experiment Video
Updated: Mar 26, 2026
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options
Gabriele Pozzato1, Cesare Mazzaro1, Luigino Dal Maso1
1Gabriele Pozzato, Francesca Zorat, Giulia Moratelli, Department of Medical and Surgical Sciences, University of Trieste, 34100 Trieste, Italy.
Insights
Hepatitis C virus (HCV) infection is linked to B-cell lymphoproliferative disorders, including non-Hodgkin's lymphoma (NHL). Antiviral therapy shows promise for treating these HCV-related lymphomas.
Area of Science:
- Hepatology
- Oncology
- Virology
Background:
- Hepatitis C virus (HCV) causes global health issues, including liver and extrahepatic diseases.
- HCV is associated with B-cell lymphoproliferative disorders like mixed cryoglobulinemia and non-Hodgkin's lymphoma (NHL).
- HCV is classified as a human cancer virus due to its association with hepatic and extrahepatic malignancies.
Purpose of the Study:
- To review recent literature on Hepatitis C virus and non-Hodgkin's lymphoma.
- To conduct a meta-analysis of epidemiological data regarding HCV and NHL.
- To discuss treatment options for HCV-related NHL, including antiviral therapy and chemotherapy.
Main Methods:
- Literature review
- Meta-analysis of epidemiological data
- Discussion of therapeutic strategies
Main Results:
- HCV is implicated in the pathogenesis of B-cell lymphoproliferative disorders.
- Common HCV-associated NHL subtypes include marginal zone, lymphoplasmacytic, and diffuse large cell lymphomas.
- NHL responsiveness to antiviral therapy supports the role of HCV in lymphomagenesis.
Conclusions:
- HCV plays a significant role in the development of NHL.
- Antiviral therapy is a viable treatment option for HCV-related NHL.
- Chemotherapy remains a potential therapeutic approach for these lymphomas.
Abstract:
Hepatitis C virus (HCV) is a global health problem affecting a large fraction of the world's population: This virus is able to determine both hepatic and extrahepatic diseases. Mixed cryoglobulinemia, a B-cell "benign" lymphoproliferative disorders, represents the most closely related as well as the most investigated HCV-related extrahepatic disorder. Since this virus is able to determine extrahepatic [non-Hodgkin's lymphoma (NHL)] as well as hepatic malignancies (hepatocellular carcinoma), HCV has been included among human cancer viruses. The most common histological types of HCV-associated NHL are the marginal zone, the lymphoplasmacytic and diffuse large cell lymphomas. The role of the HCV in the pathogenesis of the B-cell lymphoproliferative disorders is confirmed also by the responsiveness of the NHL to antiviral therapy. The purpose of this review is to provide an overview of the recent literature and a meta analysis of the epidemiology data, to explain the role of HCV in the development of NHL's lymphoma. Furthermore, the possibility to treat these HCV-related NHL with the antiviral therapy or with other therapeutic options, like chemotherapy, is also discussed.
More Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
01:25Hepatitis
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...